Author:
Nandi Jyotirmoy,Das Pratap K,Zinkievich J Michael,Baltodano Juan D,Levine Robert A
Subject
Physiology (medical),Pharmacology,Physiology
Reference39 articles.
1. New insights into prostaglandins and mucosal defense;Wallace;Aliment. Pharmacol. Ther,1995
2. The coxibs, selective inhibitors of cyclooxygenase-2;FitzGerald;N. Engl. J. Med,2001
3. Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional non-steroidal anti-inflammatory drugs, with less gastrointestinal toxicity?;Feldman;Ann. Intern. Med,2000
4. Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial. The Rofecoxib Osteoarthritis Endoscopy Multinational Study Group;Hawkey;Arthritis Rheum,2000
5. Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population;Garcia Rodriguez;Gastroenterology,2007
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献